Vasculitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 75 years old
- You are male or female
- You are generally healthy enough to take part, based on your medical history
- You are able and willing to sign a written consent form to join the study
- (Group A only) You need a short course (less than 5 days) of high-dose steroid tablets (prednisolone, at least 30mg) for an inflammatory condition, either in hospital or as an outpatient
- (Group B only) You have been taking high-dose prednisolone (more than 30mg) for at least 1 month on an ongoing basis
- (Group C only) You have been started on high-dose methylprednisolone (for more than 3 days) or a prolonged course of dexamethasone (both types of steroid)
Who may not be able to join:
- You have been diagnosed with Type 1 or Type 2 diabetes
- You are not able to give informed consent
- You are taking herbal remedies or supplements (such as St John's Wort, Cat's Claw, or Echinacea) that you are unwilling or unable to stop before and during the study
- You are taking certain medications that affect how steroids are broken down in the body (such as phenytoin, rifampicin, carbamazepine, ketoconazole, or ritonavir) and you are unwilling or unable to stop them before and during the study (confirm with trial site)
- You are pregnant — women who could become pregnant will be asked to take a urine pregnancy test at each visit
- You have any medical, mental health, or other condition, or take any medications (including over-the-counter products), that the study team believes could interfere with the study or affect your safety (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Karim Meeran, MBBS BSc MD, Imperial College London
Phone: 07555717544
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To elucidate differences in prednisolone pharmacokinetics (in patients receiving high dose prednisolone acutely and in the chronic setting).; To elucidate differences in prednisolone pharmacokinetics (in patients receiving high dose; To elucidate differences in prednisolone pharmacokinetics (in patients receiving high dose; To elucidate differences in prednisolone pharmacokinetics (in patients receiving high dose
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.